Large-scale Metabolomic Profiling Identifies Novel Biomarkers for Incident Coronary Heart Disease
暂无分享,去创建一个
Anders Larsson | Johan Sundström | Lars Lind | Andrea Ganna | Erik Ingelsson | Tove Fall | Patrik K. E. Magnusson | Nancy L. Pedersen | Samira Salihovic | Jessica Prenni | Mihkel Zilmer | Agneta Siegbahn | E. Ingelsson | L. Lind | J. Ärnlöv | A. Larsson | P. Magnusson | N. Pedersen | C. Broeckling | A. Ganna | A. Siegbahn | T. Fall | Å. Hedman | J. Sundström | J. Prenni | S. Salihović | Johan Ärnlöv | Åsa K. Hedman | Corey D. Broeckling | M. Zilmer
[1] C. Gieger,et al. Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.
[2] Large-scale non-targeted metabolomic profiling in three human population-based studies , 2014, bioRxiv.
[3] Patrik Magnusson,et al. American Journal of Epidemiology Practice of Epidemiology Risk Prediction Measures for Case-cohort and Nested Case-control Designs: an Application to Cardiovascular Disease , 2022 .
[4] Tanya M. Teslovich,et al. Common variants associated with plasma triglycerides and risk for coronary artery disease , 2013, Nature Genetics.
[5] Christian Gieger,et al. Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.
[6] Thomas J. Wang,et al. A diabetes-predictive amino acid score and future cardiovascular disease. , 2013, European heart journal.
[7] D. Shih,et al. Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis: Possible Role for Its Phospholipase-A2-Like Activity and Lysophosphatidylcholine Formation , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[8] Moshe Levi,et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.
[9] E. Ingelsson,et al. A Detailed Cardiovascular Characterization of Obesity Without the Metabolic Syndrome , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[10] A. Shevchenko,et al. Plasma Lipid Composition and Risk of Developing Cardiovascular Disease , 2013, PloS one.
[11] G. Schmitz,et al. Metabolism and atherogenic disease association of lysophosphatidylcholine. , 2010, Atherosclerosis.
[12] R. Shamburek,et al. Disappearance of two major phosphatidylcholines from plasma is predominantly via LCAT and hepatic lipase. , 1996, The American journal of physiology.
[13] L. Lind,et al. A comparison of three different methods to determine arterial compliance in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study , 2006, Journal of hypertension.
[14] Yurii S. Aulchenko,et al. Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations , 2012, PLoS genetics.
[15] L. Lind,et al. C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the prospective investigation of the Vasculature in Uppsala Seniors (PIVUS) study. , 2008, Atherosclerosis.
[16] P. McKeigue,et al. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[17] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[18] N. Webb,et al. Biology of Secretory Phospholipase A2 , 2008, Cardiovascular Drugs and Therapy.
[19] Lars Lind,et al. A Comparison of Three Different Methods to Evaluate Endothelium-Dependent Vasodilation in the Elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[20] John P A Ioannidis,et al. Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. , 2014, American journal of epidemiology.
[21] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[22] Yudi Pawitan,et al. Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies , 2015, Briefings Bioinform..
[23] M. Pencina,et al. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. , 2014, Annals of Internal Medicine.
[24] R. Abagyan,et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.
[25] Geoffrey S Ginsburg,et al. Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.
[26] M. Johannesson,et al. The Swedish Twin Registry: Establishment of a Biobank and Other Recent Developments , 2012, Twin Research and Human Genetics.
[27] N. Mehta. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.
[28] C. Broeckling,et al. Large scale non-targeted metabolomic profiling of serum by ultra performance liquid chromatography-mass spectrometry (UPLC-MS). , 2013, Journal of visualized experiments : JoVE.
[29] T. Spector,et al. Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study , 2014, Circulation.
[30] G. Rechberger,et al. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500054-JLR200 , 2005, Journal of Lipid Research.
[31] M. Fornage,et al. Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.
[32] S. Robins,et al. Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. , 1985, The Journal of laboratory and clinical medicine.
[33] J. Danesh,et al. Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .